Empress Therapeutics confirms layoffs; Nanobiotix amends J&J deal terms
Plus, news about Pyxis Oncology, Kiromic BioPharma, TC BioPharm, EnteroBiotix, Liquidia, Compass Pathways, Vincerx Pharma and Neurizon: Empress Therapeutics undergoes layoffs: A spokesperson for the Flagship-founded biotech confirmed that Empress let go 23 of 43 ...
